1. Inserm, U1037, Centre de Recherche sur le Cancer de Toulouse, Toulouse, France;
2. Centre Hospitalier Universitaire (CHU) Toulouse-Purpan and University Toulouse III Paul-Sabatier, Toulouse, France;
3. Department of Hematology, CHU Bordeaux and Inserm, U876, Université Victor Segalen, Bordeaux, France;
4. Department of Hematology, CHU Toulouse-Purpan, Toulouse, France;
5. Department of Genetics, CHU Necker, Paris, France; and
6. Departement of Pathology, CHU Toulouse-Purpan, Toulouse, France